Infection Genetics and Evolution · 2023 · 34 citations · 116 references
Life SciencesImmunologyInfectious DiseasesClinical ImmunologyImmunology Of Infectious DiseasesImmunopathologyAntiviral ImmunityT Cell BiologyCd4 Positive T CellsCd8 Positive T Cell ResponsesCd8 Positive T CellsInfectious MononucleosisT Cell-mediated Immune ResponseT-cell Immune ResponsesT-cell Mediated Immune ResponseT-cell Mediated Immunity
Epstein–Barr virus (EBV) infection is extremely common worldwide, with approximately 90% of adults testing positive for EBV antibodies. Human are susceptible to EBV infection, and primary EBV infection typically occurs early in life. EBV infection can cause infectious mononucleosis (IM) as well as some severe non-neoplastic diseases, such as chronic active EBV infection (CAEBV) and EBV-associated hemophagocytic lymphohistiocytosis (EBV-HLH), which can have a heavy disease burden. After primary EBV infection, individuals develop robust EBV-specific T cell immune responses, with EBV-specific CD8+ and part of CD4+ T cells functioning as cytotoxic T cells, defending against virus. Different proteins expressed during EBV's lytic replication and latent proliferation can cause varying degrees of cellular immune responses. Strong T cell immunity plays a key role in controlling infection by decreasing viral load and eliminating infected cells. However, the virus persists as latent infection in EBV healthy carriers even with robust T cell immune response. When reactivated, it undergoes lytic replication and then transmits virions to a new host. Currently, the relationship between the pathogenesis of lymphoproliferative diseases and the adaptive immune system is still not fully clarified and needs to be explored in the future. Investigating the T cell immune responses evoked by EBV and utilizing this knowledge to design promising prophylactic vaccines are urgent issues for future research due to the importance of T cell immunity.
116
VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA
M. A. Epstein, B. G. Achong, Y. M. Barr · The Lancet · 1964 · 2.8K citations
Jeffrey I. Cohen · New England Journal of Medicine · 2000 · 1.6K citations
Antigen-specific interaction between T and B cells
Antonio Lanzavecchia · Nature · 1985 · 1.4K citations
Jelena Levitskaya, Anatoly Sharipo, Ainars Leonchiks et al. · Proceedings of the National Academy of Sciences · 1997 · 559 citations